Surgical treatment for locally advanced lung cancer in a human immunodeficiency virus-infected patient.
Highly active antiretroviral therapy (HAART) has changed the most common cause of death among patients infected with the human immunodeficiency virus (HIV). These patients are known to be at increased risk for lung cancer compared with the general population. Recently, HIV-infected patients who need surgical treatment of lung cancers are becoming increasingly common. We present a 60-year-old HIV-infected man with locally advanced lung cancer with a helper T-lymphocyte count of 195 cells/μl at the time of lung cancer diagnosis. HAART was initiated before surgery, and extended resection was performed without discontinuance of HAART. The patient successfully recovered from surgery without complication.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.